THIS MONTH’S ISSUE

Read, save, and print articles from the current issue

ARTICLES

Chronological index
2013–2016

PRODUCT GUIDES

Compare all instruments
and software systems

DEPARTMENTS

Chronological index
2013–2016

MARKETPLACE

New pathology lab products and industry news

Home » CAP TODAY Recommends

Learn about molecular testing for M. pneumoniae

Sept. 14, 2016—Donna Mayne, the microbiology, serology, and molecular laboratory manager at Sacred Heart Health System in Pensacola, Fla., outlines the clinical benefits of using molecular technology to detect Mycoplasma pneumoniae in a free program provided by Meridian Bioscience. Watch. In a separate presentation, Vicki Chalker, PhD, head of the respiratory and vaccine-preventable bacteria reference unit of Public Health England’s National Infection Service, discusses the importance of testing for M. pneumoniae and the diagnostic methodologies available. Meridian’s M. pneumoniae test recently landed FDA clearance. Watch.

Tags:

X